Senior Research Associate, In vivo Pharmacology
Astellas Pharma
Summary
The In Vivo Senior Research Associate is responsible for executing preclinical in vivo studies and generating reliable pharmacology data to support research project decisions. This position provides specialized in vivo expertise that is essential for the successful evaluation and advancement of therapeutic candidates.
Job description
Purpose & Scope
The In Vivo Senior Research Associate is responsible for executing preclinical in vivo studies and generating reliable pharmacology data to support research project decisions. This position provides specialized in vivo expertise that is essential for the successful evaluation and advancement of therapeutic candidates.
Role and Responsibilities
- Execute and support preclinical in vivo oncology and immunotherapy studies using mouse tumor models, including xenograft and syngeneic systems.
- Perform routine animal handling, restraint, health monitoring, and study-related procedures in compliance with approved protocols and animal welfare regulations.
- Conduct in vivo procedures including intravenous (IV), intraperitoneal (IP), oral gavage, subcutaneous, and other administration routes as required.
- Perform surgical procedures and tumor implantation to establish and maintain in vivo cancer models.
- Randomize animals into study groups and monitor clinical observations, body weight, and study endpoints.
- Collect biological samples, including blood, tissues, and tumors, and ensure accurate documentation of all study activities in accordance with company SOPs and applicable regulations.
- Apply hands-on expertise in cell culture, ex vivo flow cytometry, and data analysis to support translational and pharmacology studies.
- Ensure full compliance with IACUC, institutional policies, and regulatory requirements governing animal care and use.
- Collaborate effectively with scientists and cross-functional research teams to support preclinical oncology and pharmacology programs.
- Contribute to the generation of high-quality, reliable scientific data that supports project decision-making and advancement of therapeutic candidates.
Qualifications
Required Qualifications
- BS degree in Biology, Pharmacology, Animal Science, or a related scientific discipline with 3yrs of hands-on laboratory experience supporting preclinical in vivo studies or MS degree with minimum 1yr hands-on laboratory experience in pharmaceutical or biotech industry.
- Demonstrated experience with rodent handling techniques, including tumor implantation, animal randomization, and dosing procedures (IV, IP).
- Experience performing in vivo oncology and/or immunology studies, including tumor model establishment and monitoring.
- Hands-on experience with immuno-flow cytometry, ex vivo tissue processing, tissue culture, and related biological sample analyses.
- Knowledge of animal welfare regulations and experience working in compliance with IACUC, institutional, and regulatory requirements.
Preferred Qualifications
- Experience with additional rodent dosing techniques, including IV, oral gavage (PO), subcutaneous (SC), and other specialized administration routes.
- Proven ability to independently analyze and interpret ex vivo flow cytometry data using FlowJo to support tumor immunology and mechanism-of-action studies.
- Experience supporting oncology, immunology, or pharmacology programs in a drug discovery or translational research environment.
- Familiarity with electronic laboratory and study management platforms such as Benchling, Studylog, GraphPad Prism, and FlowJo.
- Experience with advanced tissue processing, immune profiling, and biomarker analyses.
- Experience working in GLP-regulated or SOP-driven research environments.
- Experience contributing to protocol development, process optimization, or implementation of best practices in in vivo research.
Requirements
- BS degree in Biology, Pharmacology, Animal Science, or related scientific discipline with 3 years of hands-on laboratory experience supporting preclinical in vivo studies, or MS degree with minimum 1 year hands-on laboratory experience in pharmaceutical or biotech industry.
- Demonstrated experience with rodent handling techniques, including tumor implantation, animal randomization, and dosing procedures (IV, IP).
- Experience performing in vivo oncology and/or immunology studies, including tumor model establishment and monitoring.
- Hands-on experience with immuno-flow cytometry, ex vivo tissue processing, tissue culture, and related biological sample analyses.
- Knowledge of animal welfare regulations and experience working in compliance with IACUC, institutional, and regulatory requirements.
Benefits
- Medical, Dental & Vision
- Generous PTO
- 401(k) match
- Life insurance
- Annual bonus
- Quarterly sales incentive
- Long term incentive plan
- Referral bonus program
Company overview
Astellas Pharma Inc. is a leading Japanese multinational pharmaceutical company headquartered in Tokyo, Japan. Founded in April 2005 through the merger of Yamanouchi Pharmaceutical (established 1923) and Fujisawa Pharmaceutical (established 1894), Astellas has grown into a global life sciences company with operations in more than 70 countries worldwide. The company employs approximately 14,500 people globally and generates annual revenues exceeding $12 billion. Astellas is committed to turning innovative science into value for patients through transformative therapies in key therapeutic areas including oncology, ophthalmology, urology, immunology, and women's health. The company's notable products include Xtandi for prostate cancer, Padcev for bladder cancer, Xospata for acute myeloid leukemia, Veozah for menopausal symptoms, and Izervay for geographic atrophy. With a strong focus on research and development, Astellas invests approximately 17% of its sales revenue into pioneering new healthcare solutions for diseases with high unmet medical needs. The company operates multiple research centers in Japan, the United States, and Europe, and has established strategic partnerships and acquisitions to expand its pipeline and capabilities in areas such as gene therapy and immuno-oncology.